Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honest Globe was a private California company that manufactured and marketed plant-based over-the-counter, cosmetic, health, and beauty products, including the Elixicure pain-relief line. Public descriptions portray the business as a holding company focused on alternative health care and education, with in-house manufacturing capabilities in Santa Ana, California. The company appeared to operate commercially rather than as a drug-development biotech, and there is no evidence of a conventional therapeutic pipeline or clinical-stage pharmaceutical programs. Honest Globe received an FDA warning letter in March 2021 concerning CGMP deficiencies and the marketing of CBD-containing pain-relief products as unapproved drugs. Corporate registry data indicates the California entity is terminated, so it should be treated as inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Honest Globe.